Submitted Orals

Monday 14th of April 2014
14:00-15:30
SO04, 1.5 hours

Chair: Greg Peterson (Australia)

Room: Meeting room 211

14.00 – 14.15     Altering medicines to meet patient needs: pharmacists are the key to ensuring quality
(MO-21-01) Beverly Glass (Australia)

14.30 – 14.45     A comparison of anticholinergic risk scales and associations to adverse health outcomes in older people
(MO-21-03) Prasad Nishtala (New Zealand)

14.45 – 15.00      Bio regulatory requirements of pressurized metered dose inhaler (PMDI) and optimizing in-vitro characacterization of inhaler
(MO-21-04) Deepika Aggarwal (India)

15.00 – 15.15      Clinical implications of oxidized LDL in frequent-relapse minimal change nephrotic syndrome patients
(MO-21-05) Sachiko Tanaka (Japan)

15.15 – 15.30      Efficacy of a scar therapy treatment: a randomized, double-blind, controlled trial
(MO-21-06) Marina Holt (Australia)